Exploring new approaches to fetal monitoring

Research areas

Growth trajectory analysis

Investigating how individualized growth curves, rather than population-based percentiles, could improve early identification of growth restriction.

AI-assisted interpretation

Researching machine learning approaches to interpreting complex fetal data, enabling detection of subtle patterns that indicate developing complications.

Multi-modal sensing

Exploring how combining multiple sensor modalities could provide complementary signals for fetal wellbeing assessment in non-clinical settings.

Clinical integration

Studying how continuous monitoring data could integrate with existing clinical pathways, supporting clinical care.

Note. Our research is ongoing. We are currently in early-stage feasibility studies and are not making claims about clinical efficacy. We are committed to rigorous validation through proper clinical trials.

Why early detection matters

Current prenatal care relies on periodic snapshots; ultrasounds every few weeks, occasional non-stress tests. Yet conditions like fetal growth restriction (FGR) develop gradually, and warning signs often emerge between clinical visits.

Research shows that when FGR is detected early, outcomes improve dramatically; detection roughly halves stillbirth risk. But with limited sonographer availability, most women receive only 2–3 ultrasounds throughout pregnancy, leaving dangerous conditions unidentified.

The kick counting problem

Today, most mothers’ primary tool for monitoring their baby is “kick counting” – tracking fetal movements manually. But this method is time-intensive, subjective, and by the time movement patterns change noticeably, it’s often too late for intervention.

“There is urgent need to improve detection and monitoring of FGR to improve outcomes. Short-term recordings limit their utility.”Frontiers in Physiology, 2022

Impact of antenatal FGR detection on stillbirth rates

Stillbirth rate with and without antenatal fetal growth restriction (FGR) detection.

19.8per 1,000UndetectedFGR not identified before birth
9.7per 1,000DetectedFGR identified antenatally
>50% reduction
Source: Gardosi et al., BMJ 2013 (n = 92,218 pregnancies).

Methodological note. Improved outcomes in detected cases are largely due to earlier, well-timed delivery (median 10 days earlier than undetected cases). This is an observational association, not a causal claim about any single intervention. Presented for research context; Project Stardust does not make clinical efficacy claims about its own device.

What parents are asking for

50% of mothers worry about fetal movement during pregnancy and ~10% go to hospital at some point just for reassurance. Here’s what expectant parents told us they want:

Source: Berkeley Human-Centered Design parent interviews, 2025.

References

Our work builds on decades of research in maternal-fetal medicine, ultrasound imaging, and AI-assisted diagnostics.

  1. NPJ Women's Health2024Saving babies and families from preventable harm: the current state of fetoplacental monitoringRanaei-Zamani N, David AL, Siassakos D, et al.
  2. Frontiers in Physiology2022Fetal growth restriction and stillbirth: biomarkers for identifying at-risk fetusesKing VJ, Bennet L, Stone PR, Clark A, Gunn AJ, Dhillon SK.
  3. Journal of Obstetrics and Gynaecology Research2022Prediction of preterm birth using artificial intelligence: a systematic reviewAkazawa M, Hashimoto K.
  4. JAMA Health Forum2021Prenatal care services, maternal morbidity, and perinatal mortality with the advanced maternal age cutoffGeiger CK, Clapp MA, Cohen JL.
  5. The Lancet2014International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st ProjectPapageorghiou AT, Ohuma EO, Altman DG, et al.
  6. Ultrasound in Obstetrics & Gynecology2013Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the TRUFFLE studyLees C, Marlow N, Arabin B, et al.

Participate

We are enrolling people in their second or third trimester of pregnancy in a voluntary, IRB-reviewed feasibility study of an investigational wearable fetal monitoring device. Open to participants in the United States.

About the study